Clinical Research Facility
Ventura, California 93003
We've found
8 trials
at this facility
Rheumatoid Arthritis (RA) Clinical Trial
Updated: 7/26/2013
Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Despite MTX Therapy (MK-8457-008 AM6)
Status: Enrolling
Updated: 7/26/2013
Click here to add this to my saved trials
Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts) Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of FG-4592 for Treatment of Anemia in Patients With Lower Risk MDS With Low Red Blood Cell Transfusion Burden
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 2/9/2016
Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias
Status: Enrolling,
Phase
III
Updated: 2/9/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of BBT-401-1S in Ulcerative Colitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 2/9/2016
Efficacy and Safety of Amantadine HCl Extended Release Tablets to Treat Parkinson's Disease Patients With Levodopa Induced Dyskinesia.
Status: Enrolling,
Phase
III
Updated: 2/9/2016
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 4/24/2014
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials